Polyoxazoline based thermal latent curing agents for thermoset resins
US-2024270940-A1 · Aug 15, 2024 · US
US12168718B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12168718-B2 |
| Application number | US-202117348157-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 15, 2021 |
| Priority date | Jul 22, 2016 |
| Publication date | Dec 17, 2024 |
| Grant date | Dec 17, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Block copolymers have a general chemical structure of one of the formulas [A] n -[B] m and [B] n -[A] m , wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.
Opening claim text (preview).
The invention claimed is: 1. A thermoresponsive hydrogel comprising an aqueous solution of a block copolymer having a general chemical structure of one of the following formulas: [A] n -[B] m or [B] n -[A] m wherein block [A] of the block copolymer is chosen from the group consisting of 2-n-propyl-2-oxazine, 2-cyclopropyl-2-oxazine, and 2-butyl-2-oxazine, wherein block [B] of the block copolymer is chosen from the group consisting of 2-methyl-2-oxazoline and 2-ethyl-2-oxazoline, wherein n is in the range of 20 to 300, wherein m is in the range of 20 to 300, and wherein n and m have the same or approximately the same value, and wherein the block copolymer is at a concentration of at least 18 wt. % in the aqueous solution to form the thermoresponsive hydrogel. 2. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer is prepared by a two-stage co-polymerization. 3. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of one of the following formulas: wherein R is an alkyl group and R 1 is a piperdine group, wherein n is in the range of 20 to 300, wherein m is in the range of 20 to 300, and wherein n and m have the same or approximately the same value. 4. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of the formula: wherein n and m each have a value of 50. 5. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer has a general chemical structure of the following formula: wherein n and m each have a value of 100. 6. The thermoresponsive hydrogel according to claim 1 , wherein the block copolymer gels at a temperature above 10° C. 7. The thermoresponsive hydrogel according to claim 6 , wherein the block copolymer gels at a temperature above 25° C. 8. The thermoresponsive hydrogel according to claim 7 , wherein the block copolymer gels at a temperature above 30° C. 9. The thermoresponsive hydrogel according to claim 8 , wherein the block copolymer gels at a temperature above 35° C. 10. A composition which comprises an active ingredient and the thermoresponsive hydrogel according to claim 1 as a carrier material for the active agent. 11. The composition according to claim 10 , wherein the active agent is embedded in the carrier material. 12. The composition according to claim 11 , wherein the carrier material is characterized by time-delayed release or distribution of the active ingredient. 13. A drug delivery system which comprises a drug or drugs and the thermoresponsive hydrogel according to claim 1 as a carrier material for the drug or drugs. 14. The drug delivery system of claim 13 , wherein the carrier material is characterized by time-delayed release or distribution of the drug or drugs. 15. A composition which comprises cells and the thermoresponsive hydrogel according to claim 1 as a carrier material for the cells. 16. A composition which comprises one or more proteins and the thermoresponsive hydrogel according to claim 1 as a carrier material for the one or more proteins. 17. A block copolymer which has a general chemical structure of the formula: wherein n and m each have a value of 50. 18. A block copolymer which has a general chemical structure of the following formula: wherein n and m each have a value of 100. 19. The thermoresponsive hydrogel according to claim 1 , further comprising a phosphate buffer saline. 20. The thermoresponsive hydrogel according to claim 1 , further comprising one or more members selected from the group consisting of a drug, a protein, and cells.
having a macromolecular matrix · CPC title
containing added animal cells (organs or tissue containing native cells A61L27/36) · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes · CPC title
Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.